AI assistant
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2024
Feb 16, 2024
31542_dirs_2024-02-16_cacfa5b8-5285-445a-8b55-a5f22b6a9ca0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2024-02-15
Reporting Person: Elsbernd Brian (Chief Compliance/Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-15 | Common Stock, par value $0.001 per share | M | 9667 | — | Acquired | 151786 | Direct |
| 2024-02-15 | Common Stock, par value $0.001 per share | F | 2353 | — | Disposed | 149433 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-15 | Restricted Stock Units | $ | M | 9667 | Disposed | Common Stock (9667) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2: Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
F3: Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025.
F4: Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on February 15, 2024.